These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial. Simpson SH; Lier DA; Majumdar SR; Tsuyuki RT; Lewanczuk RZ; Spooner R; Johnson JA Diabet Med; 2015 Jul; 32(7):899-906. PubMed ID: 25594919 [TBL] [Abstract][Full Text] [Related]
24. Comparison of scintigraphic and echocardiographic methods in coronary heart disease. Verani MS; Zoghbi WA Am J Card Imaging; 1992 Mar; 6(1):71-80; discussion 81-2. PubMed ID: 10147616 [No Abstract] [Full Text] [Related]
25. [Perfusion scintigraphy of the heart]. van Vlies B; van Royen EA Ned Tijdschr Geneeskd; 1991 Sep; 135(37):1681-6. PubMed ID: 1922510 [No Abstract] [Full Text] [Related]
26. An overview of what diabetes can do to your body (and what you can do to prevent it). Gebel E Diabetes Forecast; 2008 Dec; 61(12):45-6. PubMed ID: 19145747 [No Abstract] [Full Text] [Related]
27. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Papaioannou GI; Seip RL; Grey NJ; Katten D; Taylor A; Inzucchi SE; Young LH; Chyun DA; Davey JA; Wackers FJ; Iskandrian AE; Ratner RE; Robinson EC; Carolan S; Engel S; Heller GV Am J Cardiol; 2004 Aug; 94(3):294-9. PubMed ID: 15276091 [TBL] [Abstract][Full Text] [Related]
28. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. Rajagopalan N; Miller TD; Hodge DO; Frye RL; Gibbons RJ J Am Coll Cardiol; 2005 Jan; 45(1):43-9. PubMed ID: 15629371 [TBL] [Abstract][Full Text] [Related]
29. [Radionuclide tests of cerebral circulation in the assessment of treatment of sensorineural hearing loss]. Karalkin AV; Petukhova NA Vestn Otorinolaringol; 2001; (1):17-9. PubMed ID: 11247238 [TBL] [Abstract][Full Text] [Related]
30. Aspirin for primary prevention of cardiovascular events in diabetes: still an open question. Nicolucci A JAMA; 2008 Nov; 300(18):2180-1. PubMed ID: 18997199 [No Abstract] [Full Text] [Related]
31. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Levy AP; Gerstein HC; Miller-Lotan R; Ratner R; McQueen M; Lonn E; Pogue J Diabetes Care; 2004 Nov; 27(11):2767. PubMed ID: 15505023 [No Abstract] [Full Text] [Related]
32. The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management. Yudkin JS J Diabetes Complications; 1996; 10(3):129-32. PubMed ID: 8807456 [No Abstract] [Full Text] [Related]
33. [Prevention of cardiovascular disease in type 2 diabetes]. Paquot N; Scheen AJ Rev Med Liege; 2003 May; 58(5):271-4. PubMed ID: 12940113 [TBL] [Abstract][Full Text] [Related]
34. Guidelines and their use in clinical practice. Shaw JA; Cooper ME Diab Vasc Dis Res; 2014 Jan; 11(1):3-4. PubMed ID: 24344118 [No Abstract] [Full Text] [Related]
35. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ; Diabetes Care; 2007 Jan; 30(1):162-72. PubMed ID: 17192355 [TBL] [Abstract][Full Text] [Related]
36. Ways to reduce cardiovascular disease in diabetes. Garg SK; DiDomenico D; Switzer S Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S1-2. PubMed ID: 22650219 [No Abstract] [Full Text] [Related]
37. [Heart and circulatory disorders in diabetics. Prognostic indices and preventive measures]. Janka HU Lebensversicher Med; 1983 Nov; 35(9):202-6. PubMed ID: 6140609 [No Abstract] [Full Text] [Related]
38. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Chen YH; Feng B; Chen ZW Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291 [TBL] [Abstract][Full Text] [Related]
39. Summaries of nursing care-related systematic reviews from the Cochrane Library: adenosine-diphosphate receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Zheng S; Min Z; Yanqing H J Cardiovasc Nurs; 2013; 28(5):405-6. PubMed ID: 23938327 [No Abstract] [Full Text] [Related]
40. Inhibition of the RAS and prevention of diabetes and CVD: mechanistic insights and lessons learned from clinical trials. McFarlane SI; Borer JS Curr Diab Rep; 2009 Feb; 9(1):1-3. PubMed ID: 19192416 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]